Physician profile
Samuel Shinkle
NPI 1558735514
$10,482.98
in general payments reported to CMS, 2019-2025
45 companies · $2,789 in 2025
The $2,789 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,220 · 2023: $2,599 · 2024: $2,874 · 2025: $2,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,263.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,330.96 | 2022-2025 | Repatha, Repatha, Evenity |
| Pfizer INC. | $903.42 | 2022-2025 | |
| Abbvie INC. | $725.88 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $655.12 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $591.12 | 2022-2025 | Emgality, Mounjaro, Reyvow |
| Novo Nordisk INC | $495.20 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $477.66 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.52 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Phathom Pharmaceuticals, INC. | $268.10 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $262.91 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $251.97 | 2022-2025 | |
| Exact Sciences Corporation | $184.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Antares Pharma, INC. | $173.91 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Teva Pharmaceuticals USA, INC. | $125.30 | 2022-2025 | Austedo Xr, Ajovy, Austedo |
| Axsome Therapeutics, INC. | $120.84 | 2023-2025 | Auvelity, Symbravo |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $114.06 | 2022-2025 | Azstarys |
| Shield Therapeutics INC | $103.07 | 2024 | |
| Dexcom, INC. | $102.94 | 2024-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $99.40 | 2022-2024 | Spravato |
| Astellas Pharma US INC | $96.45 | 2023-2025 | Veozah |
| Abbott Laboratories | $89.46 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Sanofi-Aventis U.S. LLC | $85.91 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $83.51 | 2025 | Recorlev |
| Edwards Lifesciences Corporation | $56.56 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Corcept Therapeutics | $52.11 | 2023-2025 | Korlym |
| Halozyme INC | $49.31 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.03 | 2022-2025 | Trintellix |
| Ironshore Pharmaceuticals INC. | $47.31 | 2023 | Jornay Pm |
| Mylan Specialty L.P. | $46.68 | 2022-2024 | Yupelri |
| Exeltis, USA INC. | $41.59 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.08 | 2022 | |
| Medtronic, INC. | $40.01 | 2024-2025 | Inceptiv, Minimed 780g |
| Mayne Pharma Commercial LLC | $39.21 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.76 | 2023-2024 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $35.33 | 2022-2025 | Gardasil 9, Rotateq, Capvaxive |
| Organon LLC | $31.47 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.93 | 2022-2025 | Eliquis |
| Lucid Diagnostics INC. | $29.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $24.91 | 2024 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $23.46 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.75 | 2024 | |
| Collegium Pharmaceutical, INC. | $18.80 | 2025 | Jornay Pm |
| Lundbeck LLC | $18.74 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.02 | 2025 | Zoryve |
| Idorsia Pharmaceuticals US INC | $12.98 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Shinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.